RxDoctor Payments Data

Jorge Arzola Colon, MD

Vascular & Interventional Radiology · Hato Rey, PRNPI 1871514646

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Medtronic at 33.4% of the total. Reporting peaked in 2024 at $497 and has fallen 80.4% since, to $97 in 2025.

$1,452in general payments, 2019–2025

Across 28 payments — averaging $51.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$484
  • Boston Scientific$311
  • Bard Access Systems, Inc.$166
  • Davol Inc.$118
  • Johnson & Johnson$98
  • Terumo Medical Corporation$96
  • plus $177 from 3 others

What the payments were for

  • Food & beverage$1,452100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)9$484
Boston Scientific8$311
Bard Access Systems, Inc.1$166
Davol Inc.1$118
Johnson & Johnson4$98
Terumo Medical Corporation1$96
BD1$94
Cardinal Health P.r. 120 Inc2$72
Abbott1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,452 in reported general payments places this provider in the 60th percentile of 27 vascular & interventional radiology providers in Puerto Rico.

See all vascular & interventional radiology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$14,651
Medicare patients
42
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban44$34,147
Lorazepam11$26

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$98$34,14744 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 27 vascular & interventional radiology providers in Puerto Rico.

Other vascular & interventional radiology in Hato Rey

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →